Parkman Healthcare Partners LLC Zymeworks Inc. Transaction History

Parkman Healthcare Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$4.82 - $7.7 $31,426 - $50,204	6,520 Added 5.47%	125,806 $667,000
Q1 2022 May 13, 2022	BUY	$6.0 - $16.98 $465,966 - $1.32 Million	77,661 Added 186.57%	119,286 $781,000
Q4 2021 Feb 11, 2022	BUY	$15.19 - $29.33 $176,583 - $340,961	11,625 Added 38.75%	41,625 $682,000
Q3 2021 Nov 12, 2021	BUY	$27.35 - $37.28 $820,500 - $1.12 Million	30,000 New	30,000 $871,000
Q4 2020 Feb 12, 2021	SELL	$39.12 - $54.99 $3.33 Million - $4.67 Million	-85,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$29.21 - $46.58 $2.48 Million - $3.96 Million	85,000 New	85,000 $3.96 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $906M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.